Steroid dexamethasone reduces deaths among patients with severe Covid-19, trial shows

Giving low doses of the generic steroid drug dexamethasone to patients admitted to hospital with Covid-19 reduced death rates by around a third among those with the most severe cases of infection, trial data showed on Tuesday.The results, described as a "major breakthrough" by scientists leading the UK-led clinical trial known as RECOVERY, suggest the drug should immediately become standard care in patients treated in hospital with the pandemic disease, the researchers said.

from UK News Headlines, Latest UK News and Live Updates - Times of India https://ift.tt/37xKiER